Bortezomib potentiates the antitumor effect of tributyltin(IV) ferulate in colon cancer cells exacerbating ER stress and promoting apoptosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bortezomib potentiates the antitumor effect of tributyltin(IV) ferulate in colon cancer cells exacerbating ER stress and promoting apoptosis
Authors
Keywords
-
Journal
INORGANICA CHIMICA ACTA
Volume 537, Issue -, Pages 120929
Publisher
Elsevier BV
Online
2022-03-27
DOI
10.1016/j.ica.2022.120929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
- (2021) Sonia Emanuele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells
- (2021) Michela Giuliano et al. MOLECULES
- The efficacy and mechanism of proteasome inhibitors in solid tumor treatment
- (2021) Lei Zhang et al. Recent Patents on Anti-Cancer Drug Discovery
- New Insights into Curcumin- and Resveratrol-Mediated Anti-Cancer Effects
- (2021) Andrea Arena et al. Pharmaceuticals
- Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects
- (2020) Claudia Pellerito et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- p62: Friend or Foe? Evidences for OncoJanus and NeuroJanus Roles
- (2020) Sonia Emanuele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma
- (2020) Fazal Shirazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy
- (2020) Jin Hee Lee et al. Scientific Reports
- Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
- (2019) Pawel Robak et al. Drugs in research & development
- Proteasome Inhibitor Drugs
- (2019) Lloyd D. Fricker Annual Review of Pharmacology and Toxicology
- FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53
- (2019) Ming Xu et al. CARCINOGENESIS
- The Anti-Cancer Effect of Mangifera indica L. Peel Extract is Associated to γH2AX-mediated Apoptosis in Colon Cancer Cells
- (2019) Marianna Lauricella et al. Antioxidants
- p53-Mediated Oxidative Stress Enhances Indirubin-3′-Monoxime-Induced Apoptosis in HCT116 Colon Cancer Cells by Upregulating Death Receptor 5 and TNF-Related Apoptosis-Inducing Ligand Expression
- (2019) Matharage Gayani Dilshara et al. Antioxidants
- Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents
- (2018) Jai Devi et al. Anti-Cancer Agents in Medicinal Chemistry
- The Double-Edged Sword Profile of Redox Signaling: Oxidative Events As Molecular Switches in the Balance between Cell Physiology and Cancer
- (2018) Sonia Emanuele et al. CHEMICAL RESEARCH IN TOXICOLOGY
- 2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy
- (2018) Yuan Qing Qu et al. Cell Death & Disease
- Antioxidant Properties of Ferulic Acid and Its Possible Application
- (2018) Kamila Zduńska et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
- Sequential treatment with celecoxib and bortezomib enhances the ER stress‑mediated autophagy‑associated cell death of colon cancer cells
- (2018) Ga‑Bin Park et al. Oncology Letters
- Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death
- (2018) In Young Kim et al. BIOCHEMICAL PHARMACOLOGY
- Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma
- (2016) Masaki Ri INTERNATIONAL JOURNAL OF HEMATOLOGY
- Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor
- (2016) Tingyu Wu et al. MOLECULAR CANCER THERAPEUTICS
- The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells
- (2015) ANTONIETTA NOTARO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Synthesis, chemical characterization, computational studies and biological activity of new DNA methyltransferases (DNMTs) specific inhibitor. Epigenetic regulation as a new and potential approach to cancer therapy
- (2015) C. Pellerito et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synthesis, chemical characterization and biological activity of new histone acetylation/deacetylation specific inhibitors: A novel and potential approach to cancer therapy
- (2013) Ornella Pellerito et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Tri- and diorganotin(IV) complexes of biologically important orotic acid: Synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities
- (2012) Mala Nath et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Good Caco-2 cell culture practices
- (2012) Manuela Natoli et al. TOXICOLOGY IN VITRO
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting
- (2011) Min Ni et al. BIOCHEMICAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now